Serial 79446101
Live / Applied — Non-final action mailed (as of 06 Sept 2026)
What this means for you
Not registered yet, but its 23 Jan 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79446101
- Mark type
- Design / logo
- Filed
- 23 Jan 2026
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of orphan diseases, namely, inherited disorders of the immune system, inherited metabolic disorders, inherited blood disorders, inherited neuro-degenerative disorders; chemical preparations for pharmaceutical or medical purposes for use in gene therapy for the treatment of orphan diseases, namely, inherited disorders of the immune system, inherited metabolic disorders, inherited blood disorders, inherited neuro-degenerative disorders; medicinal preparations for the treatment of orphan diseases, namely, inherited disorders of the immune system, inherited metabolic disorders, inherited blood disorders, inherited neuro-degenerative disorders
Owner
Prosecution history
- 06 Sept 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 06 Sept 2026 — REFUSAL PROCESSED BY MPU
- 27 May 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 26 May 2026 — NON-FINAL ACTION WRITTEN
- 20 May 2026 — ASSIGNED TO EXAMINER
- 27 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 27 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 25 Mar 2026 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
- 19 Mar 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB